Biotech China 2014
Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics


Cambridge, Massachusetts
http://www.healthtech.com/imt/clv
Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics 

Schedule of Presentations:

Wednesday, August 18, 2010
12:15:00 Registration
13:45:00 Opening Remarks Bruce L. Levine
13:50:00 Keynote Presentation George Siber
14:25:00 IDENTIFYING BIOMARKERS FOR IMMUNE RESPONSE Danilo Casimiro,
14:30:00 Development of Biomarkers of Vaccine Efficacy Against Chronic Viral Infections Danilo Casimiro,
15:00:00 Identify Correlates of Protection Biomarker in Vaccine Development Yiwu He
15:30:00 Ice Cream Bar Refreshment Break with Exhibit and Poster Viewing
16:15:00 An Integrative Paradigm for Biomarker Development in Immunotherapy Clinical Trials-Lessons Learned and Future Directions Michael Kalos
16:45:00 High Resolution Immunomonitoring to Identify Correlates to Clinical Outcome Charles A. Nicolette
17:10:00 ANALYZING POST-MARKETING SURVEILLANCE AND EPIDEMIOLOGY
17:15:00 Cohort Event Monitoring – A Description of Methodology and Tools Magnus Wallberg
17:45:00 Risk Management Strategies for Immunotherapeutics Pre- and Post-Approval Michael Forstner
18:15:00 End of Day
Thursday, August 19, 2010
07:30:00 Morning Coffee (Breakfast Sponsored Presentation Opportunity Available)
08:20:00 STANDARDIZING IMMUNOGENICITY TESTING
08:25:00 Chairperson’s Remarks Michael G. Hanna
08:30:00 Standardization of Immunogenicity Testing Across Species Travis Harrison
09:00:00 Talk Title to be Announced Andrew T. Parsa
09:30:00 Cancer Vaccine Forum Immunotherapies & Adjuvants
09:35:00 Moderator: Bruce L. Levine
09:40:00 Panelists: Robert Hawkins, Andrew T. Parsa, James Gulley, Michael Kalos
10:00:00 Networking Coffee Break
10:20:00 SELECTING THE BEST PRE-CLINICAL ANIMAL MODELS
10:25:00 Chairperson’s Remarks Bruce L. Levine
10:30:00 Strategies for the Non-Clinical Safety Assessment of Vaccines Jayanthi Wolf
11:00:00 Genomics-Based Individualized Immunotherapy of Human Cancers: Some Baby Steps Pramod K. Srivastava
11:30:00 Engineering T-cells for Cancer Therapy Robert Hawkins
12:00:00 Sponsored Presentation (Opportunity Available)
12:15:00 Luncheon Presentation (Opportunity Available) or Lunch on Your Own
13:50:00 Evaluation of the Safety and Efficacy of a Novel RSV F Particle Vaccine in the Cotton Rat Ramadevi Raghunandan
14:15:00 NAVIGATING CHANGING REGULATORY REQUIREMENTS
14:20:00 Perspectives on the Changing Regulatory Paradigm Elaine Esber
14:50:00 Regulation of Cellular Immunotherapy Products - Common Obstacles and Strategies for Success Scott R. Burger
15:20:00 Networking Refreshment Break
15:35:00 Synthetic Peptide Vaccine for Pandemic Influenza Douglas Powell
16:05:00 Navigating the Regulatory Minefield with a Novel Cell Substrate Daniel D. Adams
16:35:00 End of ImVacS Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.